Sell RIM!: Against ...
Abiomed Inc. (ABMD: NASDAQ)
$19.77 0.86 | 4.55%
06/04/12 - 04:00 PM ET
Company Income Statement
| Mar 2012 | Mar 2011 | Mar 2010 | Mar 2009 | |
| Sales | 126.38M | 101.15M | 85.71M | 73.21M |
| Cost of Sales | 24.51M | 19.42M | 19.10M | 17.03M |
| Gross Operating Profit | 101.87M | 81.73M | 66.61M | 56.18M |
| Selling, General, and Administrative Expenses | 71.71M | 62.29M | 60.84M | 55.36M |
| Research & Development | 27.16M | 26.68M | 25.95M | 25.33M |
| Operating Income before D & A (EBITDA) | 3.00M | -7.24M | -20.18M | -24.50M |
| Depreciation & Amortization | 1.48M | 3.95M | 4.90M | 5.02M |
| Interest Income | n.a. | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 1.02M | 322.00K | 6.72M | -1.33M |
| Special Income / Charges | n.a. | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 2.54M | -10.86M | -18.35M | -30.84M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-Tax Income | 2.54M | -10.86M | -18.35M | -30.84M |
| Income Taxes | 1.05M | 892.00K | 671.00K | 752.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 1.50M | -11.76M | -19.02M | -31.60M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 1.50M | -11.76M | -19.02M | -31.60M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 1.50M | -11.76M | -19.02M | -31.60M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
n.a. | -11.76M | -19.02M | -31.60M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 0.00 | -11.76M | -19.02M | -31.60M |
| Basic EPS from Continuing Ops. | 0.04 | -0.32 | -0.52 | -0.91 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 0.04 | -0.32 | -0.52 | -0.91 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 0.04 | -0.32 | -0.52 | -0.91 |
| Basic Normalized Net Income/Share | n.a. | -0.32 | -0.52 | -0.91 |
| EPS fr Continuing Ops. | 0.04 | -0.32 | -0.52 | -0.91 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 0.04 | -0.32 | -0.52 | -0.91 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 0.04 | -0.32 | -0.52 | -0.91 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
n.a. | -0.32 | -0.52 | -0.91 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ABMD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Top Morningstar M&A Stoc...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks At New 52-Week Highs...
- ContributorTop Stocks of the 10 Best M...
- UserPART 6 JPMorgan 28th Annual...
- User52 week high 52 week low
- UserRAPTOR SPRTD-1102091914
- UserPART 5 JPMorgan 27th Annual...
Latest ABMD Headlines from TheStreet
- Abiomed Stock Falls On Unusually High Volume (ABMD) 05.22.12 | 04:05 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 05.16.12 | 09:05 am
- Abiomed Stock Hits New 52-Week High (ABMD) 05.01.12 | 10:05 am
- 'Mad Money Lightning Round': Caution on Citigroup 03.02.12 | 07:03 pm
- Abiomed Rises On Unusually High Volume (ABMD) 02.08.12 | 03:02 pm
- Abiomed Stock Falls On Unusually High Volume (ABMD) 02.07.12 | 12:02 pm
- Abiomed Reaches New 52-Week High (ABMD) 02.06.12 | 11:02 am
- 8 Stocks Soaring on Unusual Volume 02.03.12 | 04:02 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 02.03.12 | 08:02 am
- 10 Top Morningstar M&A Stock Picks for 2012 01.20.12 | 01:01 pm
Press Releases for ABMD
- Abiomed To Present At Deutsche Bank 37Th Annual Healthcare Conference - Business Wire 05.01.12 | 08:05 am
- Abiomed Receives CE Mark For Impella CVAD - Business Wire 04.12.12 | 08:04 am
- Abiomed Announces First Patient Supported With Impella CVAD - Business Wire 04.03.12 | 08:04 am
- Abiomed Appoints Susan Vissers Lisa As Senior Director Of Investor Relations And Corporate Development - Business Wire 03.21.12 | 08:03 am
- Abiomed Announces Schedule Of Events At American College Of Cardiology 2012 Scientific Sessions - Business Wire 03.20.12 | 08:03 am
- Abiomed To Present At The Cowen 32nd Annual Healthcare Conference - Business Wire 03.02.12 | 11:03 am
- Abiomed To Present At Citi 2012 Global Healthcare Conference - Business Wire 02.22.12 | 08:02 am
- Abiomed Reports Record Revenue Of $32.2 Million And Earnings Of $2.9 Million For Third Quarter Of Fiscal 2012 - Business Wire 02.03.12 | 07:02 am
- New Clinical Data For Symphony Presented In Late Breaking Clinical Trials Session At The Society Of Thoracic Surgeons 2012 Annual Meeting - Business Wire 01.31.12 | 08:01 am
- Abiomed Third Quarter Fiscal 2012 Earnings And Conference Call Notification - Business Wire 01.26.12 | 12:01 pm
Partner Headlines for ABMD
- Abiomed Beats, Posts Profit - Analyst Blog - Zacks 05.17.12 | 10:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.09.12 | 09:04 am
- Abiomed Tops, Swings to Black - Analyst Blog - Zacks 02.06.12 | 09:02 am
- Wunderlich Maintains Buy, $24 Target on Abiomed - Benzinga 12.12.11 | 09:12 am
- Abiomed Raised to Outperform - Analyst Blog - Zacks 11.11.11 | 07:11 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 11.07.11 | 09:11 am
- Neutral View on Abiomed - Analyst Blog - Zacks 08.16.11 | 06:08 pm
- Healthcare Stocks in the News on Tuesday - Seeking Alpha 06.29.11 | 09:06 am
- UPDATE 1-US FDA warns Abiomed on marketing of heart pump - Reuters 06.28.11 | 11:06 am
- Cramer's Mad Money - 6 Earnings to Watch in the Coming Week (6/3/11) - Seeking Alpha 06.05.11 | 06:06 am





